1h Free Analyst Time
The publisher has been monitoring the meningococcal vaccines market and it is poised to grow by $1.68 bn during 2021-2025, progressing at a CAGR of 8.94% during the forecast period. The report on the meningococcal vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in pediatric population and initiatives from government agencies.
The meningococcal vaccines market analysis includes composition segment and geographic landscape.
The meningococcal vaccines market is segmented as below:
By Composition
- Mono vaccines
- Combination vaccines
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the recent drug approvals and product innovation as one of the prime reasons driving the meningococcal vaccines market growth during the next few years.
The report on meningococcal vaccines market covers the following areas:
- Meningococcal vaccines market sizing
- Meningococcal vaccines market forecast
- Meningococcal vaccines market industry analysis
The publisher robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading meningococcal vaccines market vendors that include Baxter International Inc., Bio-Med Pvt. Ltd., GlaxoSmithKline Plc, Incepta Vaccine Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Walvax Biotechnology Co. Ltd.Also, the meningococcal vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Composition
- Market segments
- Comparison by Composition
- Mono vaccines - Market size and forecast 2020-2025
- Combination vaccines - Market size and forecast 2020-2025
- Market opportunity by Composition
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Baxter International Inc.
- Bio-Med Pvt. Ltd.
- GlaxoSmithKline Plc
- Incepta Vaccine Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- Walvax Biotechnology Co. Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Exhibits 1: Key Finding 1
- Exhibits 2: Key Finding 2
- Exhibits 3: Key Finding 3
- Exhibits 4: Key Finding 5
- Exhibits 5: Key Finding 6
- Exhibits 6: Key Finding 7
- Exhibits 7: Key Finding 8
- Exhibits 8: Parent market
- Exhibits 9: Market characteristics
- Exhibits 10: Offerings of vendors included in the market definition
- Exhibits 11: Market segments
- Exhibits 12: Global - Market size and forecast 2020 - 2025 ($ million)
- Exhibits 13: Global market: Year-over-year growth 2020 - 2025 (%)
- Exhibits 14: Five forces analysis 2020 & 2025
- Exhibits 15: Bargaining power of buyers
- Exhibits 16: Bargaining power of suppliers
- Exhibits 17: Threat of new entrants
- Exhibits 18: Threat of substitutes
- Exhibits 19: Threat of rivalry
- Exhibits 20: Market condition - Five forces 2020
- Exhibits 21: Composition - Market share 2020-2025 (%)
- Exhibits 22: Comparison by Composition
- Exhibits 23: Mono vaccines - Market size and forecast 2020-2025 ($ million)
- Exhibits 24: Mono vaccines - Year-over-year growth 2020-2025 (%)
- Exhibits 25: Combination vaccines - Market size and forecast 2020-2025 ($ million)
- Exhibits 26: Combination vaccines - Year-over-year growth 2020-2025 (%)
- Exhibits 27: Market opportunity by Composition
- Exhibits 28: Customer landscape
- Exhibits 29: Market share By Geographical Landscape 2020-2025 (%)
- Exhibits 30: Geographic comparison
- Exhibits 31: North America - Market size and forecast 2020-2025 ($ million)
- Exhibits 32: North America - Year-over-year growth 2020-2025 (%)
- Exhibits 33: Europe - Market size and forecast 2020-2025 ($ million)
- Exhibits 34: Europe - Year-over-year growth 2020-2025 (%)
- Exhibits 35: Asia - Market size and forecast 2020-2025 ($ million)
- Exhibits 36: Asia - Year-over-year growth 2020-2025 (%)
- Exhibits 37: ROW - Market size and forecast 2020-2025 ($ million)
- Exhibits 38: ROW - Year-over-year growth 2020-2025 (%)
- Exhibits 39: Key leading countries
- Exhibits 40: Market opportunity By Geographical Landscape ($ million)
- Exhibits 41: Impact of drivers and challenges
- Exhibits 42: Vendor landscape
- Exhibits 43: Landscape disruption
- Exhibits 44: Industry risks
- Exhibits 45: Vendors covered
- Exhibits 46: Market positioning of vendors
- Exhibits 47: Baxter International Inc. - Overview
- Exhibits 48: Baxter International Inc. - Business segments
- Exhibits 49: Baxter International Inc. - Key offerings
- Exhibits 50: Baxter International Inc. - Key customers
- Exhibits 51: Baxter International Inc. - Segment focus
- Exhibits 52: Bio-Med Pvt. Ltd. - Overview
- Exhibits 53: Bio-Med Pvt. Ltd. - Product and service
- Exhibits 54: Bio-Med Pvt. Ltd. - Key offerings
- Exhibits 55: Bio-Med Pvt. Ltd. - Key customers
- Exhibits 56: Bio-Med Pvt. Ltd. - Segment focus
- Exhibits 57: GlaxoSmithKline Plc - Overview
- Exhibits 58: GlaxoSmithKline Plc - Business segments
- Exhibits 59: GlaxoSmithKline Plc - Key offerings
- Exhibits 60: GlaxoSmithKline Plc - Key customers
- Exhibits 61: GlaxoSmithKline Plc - Segment focus
- Exhibits 62: Incepta Vaccine Ltd. - Overview
- Exhibits 63: Incepta Vaccine Ltd. - Product and service
- Exhibits 64: Incepta Vaccine Ltd. - Key offerings
- Exhibits 65: Incepta Vaccine Ltd. - Key customers
- Exhibits 66: Incepta Vaccine Ltd. - Segment focus
- Exhibits 67: Merck and Co. Inc. - Overview
- Exhibits 68: Merck and Co. Inc. - Business segments
- Exhibits 69: Merck and Co. Inc. - Key offerings
- Exhibits 70: Merck and Co. Inc. - Key customers
- Exhibits 71: Merck and Co. Inc. - Segment focus
- Exhibits 72: Novartis AG - Overview
- Exhibits 73: Novartis AG - Business segments
- Exhibits 74: Novartis AG - Key offerings
- Exhibits 75: Novartis AG - Key customers
- Exhibits 76: Novartis AG - Segment focus
- Exhibits 77: Pfizer Inc. - Overview
- Exhibits 78: Pfizer Inc. - Business segments
- Exhibits 79: Pfizer Inc. - Key offerings
- Exhibits 80: Pfizer Inc. - Key customers
- Exhibits 81: Pfizer Inc. - Segment focus
- Exhibits 82: Sanofi SA - Overview
- Exhibits 83: Sanofi SA - Business segments
- Exhibits 84: Sanofi SA - Key offerings
- Exhibits 85: Sanofi SA - Key customers
- Exhibits 86: Sanofi SA - Segment focus
- Exhibits 87: Serum Institute of India Pvt. Ltd. - Overview
- Exhibits 88: Serum Institute of India Pvt. Ltd. - Product and service
- Exhibits 89: Serum Institute of India Pvt. Ltd. - Key offerings
- Exhibits 90: Serum Institute of India Pvt. Ltd. - Key customers
- Exhibits 91: Serum Institute of India Pvt. Ltd. - Segment focus
- Exhibits 92: Walvax Biotechnology Co. Ltd.- Overview
- Exhibits 93: Walvax Biotechnology Co. Ltd.- Product and service
- Exhibits 94: Walvax Biotechnology Co. Ltd.- Key offerings
- Exhibits 95: Walvax Biotechnology Co. Ltd.- Key customers
- Exhibits 96: Walvax Biotechnology Co. Ltd.- Segment focus
- Exhibits 97: Currency conversion rates for US$
- Exhibits 98: Research Methodology
- Exhibits 99: Validation techniques employed for market sizing
- Exhibits 100: Information sources
- Exhibits 101: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global meningococcal vaccines market: Baxter International Inc., Bio-Med Pvt. Ltd., GlaxoSmithKline Plc, Incepta Vaccine Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Walvax Biotechnology Co. Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is recent drug approvals and product innovation.`
According to the report, one of the major drivers for this market is the increase in pediatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Baxter International Inc.
- Bio-Med Pvt. Ltd.
- GlaxoSmithKline Plc
- Incepta Vaccine Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- Walvax Biotechnology Co. Ltd.
